About XstalBio
XstalBio is a company based in Glasgow (United Kingdom) founded in 2004. XstalBio offers products and services including Circular Dichroism Service and Proprietary Technology Licensing.
- Headquarter Glasgow, United Kingdom
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website xstalbio.com
- Social LinkedIn X
- Legal Name Xstalbio Limited
- Latest Funding Round$465.74K (USD), Grant
Apr 2015
- Investors
Products & Services of XstalBio
XstalBio offers a comprehensive portfolio of products and services, including Circular Dichroism Service and Proprietary Technology Licensing.
Circular Dichroism is utilized to measure bio-stability and vaccine potency for drug substances and drug products.
Proprietary technologies are licensed to address bioformulation and delivery issues, including sustained release of biologics and thermally stable vaccines.
Funding Insights of XstalBio
- Total Rounds 2
- Last Round Grant — $465,740
- First Round $516,585
(Jan 2015)
- Investors Count 1
All 2 funding rounds of XstalBio with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2015 | $465,740 | Grant | – | – | |
| Jan 2015 | $516,585 | Grant | – | – |
1 investors in total: 1 institutional.
Investors in XstalBio
XstalBio has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium |
Investor details for XstalBio
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of XstalBio
3 dated milestones of XstalBio across 11 years, from founding to its latest funding, stage changes and deals.
- Founded XstalBio is founded.
- Funding First funding round of $517K.
- Funding Latest funding round, Grant, of $466K.
Web traffic of XstalBio
Websites that share an audience with XstalBio (xstalbio.com).
Websites whose visitors overlap most with XstalBio. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| noven.com | 83% | 7.2K | #3,107,578 | View details |
Similar companies to XstalBio
10 companies that operate in the same segment as XstalBio (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Drug discovery and development services are provided to biopharma sector. | 1993 | Hamburg, Hamburg, Germany | USD 25 M | USD 926.33 M | 4,830 | |
Drug discovery and development services for small molecules are provided. | 2003 | Beijing, China | USD 320 M | – | 476 | |
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 255.15 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
Pharmaceutical products for treating multiple diseases are provided. | 1849 | New York, New York, United States | USD 8 M | USD 266.99 M | 1,770 | |
Provider of laboratory tests for physicians | 1969 | Burlington, Vermont, United States | – | USD 13.95 B | 70,000 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about XstalBio
XstalBio was founded in 2004 and raised its 1st funding round 11 years after it was founded.
XstalBio is headquartered in Glasgow, United Kingdom. It is registered at Glasgow, Scotland, United Kingdom.
Provider of bioformulation and drug delivery technologies for biologics and vaccines. It focuses on formulation and delivery of biologics through injection, inhalation, oral, and nasal routes. It formulates APIs including mAbs, mAb fragments, cytokines, hormones, plasmids, and peptides. The company also offers solid-state circular dichroism services for measuring bio-stability and vaccine potency. It has proprietary technology available for licensing that addresses bioformulation and delivery challenges, such as high concentration protein solutions, sustained release of biologics, thermally stable vaccines, and dry biologic powders for inhalation.
XstalBio offers Circular Dichroism Service and Proprietary Technology Licensing.
XstalBio has 1 investor. Key investors include European Union.
XstalBio operates through Xstalbio Limited.